These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30746581)

  • 1. Clinical and MRI response to dose reduction of an etanercept-biosimilar for hip arthritis in patients with ankylosing spondylitis: an observational, retrospective cohort study.
    Huang ZX; Deng WM; Guo X; Huang ZP; Huang YK; Lin CL; Li TW
    Clin Rheumatol; 2019 Jun; 38(6):1595-1604. PubMed ID: 30746581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose reduction of recombinant human tumor necrosis factor inhibitors (etanercept) can be effective in ankylosing spondylitis patients with synovitis of the hip in a Chinese population.
    Li J; Wang X; Han Z; Zhang Y; Wang Y; Zhang Y; Li W
    Int J Immunopathol Pharmacol; 2016 Sep; 29(3):510-5. PubMed ID: 27381286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective serum level of etanercept biosimilar and effect of antidrug antibodies on drug levels and clinical efficacy in Chinese patients with ankylosing spondylitis.
    Dong Y; Li P; Xu T; Bi L
    Clin Rheumatol; 2019 Jun; 38(6):1587-1594. PubMed ID: 30747393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of dose reduction strategy of etanercept in patients with axial spondyloarthritis.
    Lian F; Zhou J; Wang Y; Chen D; Xu H; Liang L
    Clin Exp Rheumatol; 2018; 36(5):884-890. PubMed ID: 29652659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clinical and MRI Effect of TNF-α Inhibitors in Spondyloarthritis Patients With Hip Involvement: A Real-World Observational Clinical Study.
    Zhang K; Zheng Y; Han Q; Liu Y; Wang W; Ding J; Wang Y; Zhang B; Jia J; Zheng M; Zheng Z; Zhu P
    Front Immunol; 2021; 12():740980. PubMed ID: 34659233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of therapeutic response in ankylosing spondylitis patients undergoing anti-tumour necrosis factor therapy by whole-body magnetic resonance imaging.
    Karpitschka M; Godau-Kellner P; Kellner H; Horng A; Theisen D; Glaser C; Brandlhuber B; Reiser M; Weckbach S
    Eur Radiol; 2013 Jul; 23(7):1773-84. PubMed ID: 23494493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quick decrease of bone marrow edema in sacroiliac joint could be served as a novel marker for dose tapering of etanercept in ankylosing spondylitis patients.
    Yang R; Liu H; Fan M
    Medicine (Baltimore); 2019 Mar; 98(11):e14620. PubMed ID: 30882628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Long-Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104-Week Results From a Randomized, Placebo-Controlled Study.
    Dougados M; van der Heijde D; Sieper J; Braun J; Citera G; Lenaerts J; van den Bosch F; Wei JC; Pedersen R; Bonin R; Jones H; Marshall L; Logeart I; Vlahos B; Bukowski JF; Maksymowych WP
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1590-1598. PubMed ID: 28482137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TNF-alpha therapy for ankylosing spondylitis.
    Son JH; Cha SW
    Clin Orthop Surg; 2010 Mar; 2(1):28-33. PubMed ID: 20190998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
    van Herwaarden N; den Broeder AA; Jacobs W; van der Maas A; Bijlsma JW; van Vollenhoven RF; van den Bemt BJ
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010455. PubMed ID: 25264908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly.
    Braun J; McHugh N; Singh A; Wajdula JS; Sato R
    Rheumatology (Oxford); 2007 Jun; 46(6):999-1004. PubMed ID: 17389658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.
    Gorman JD; Sack KE; Davis JC
    N Engl J Med; 2002 May; 346(18):1349-56. PubMed ID: 11986408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.
    Brandt J; Khariouzov A; Listing J; Haibel H; Sörensen H; Grassnickel L; Rudwaleit M; Sieper J; Braun J
    Arthritis Rheum; 2003 Jun; 48(6):1667-75. PubMed ID: 12794835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open-Label, Non-Mandatory Transitioning From Originator Etanercept to Biosimilar SB4: Six-Month Results From a Controlled Cohort Study.
    Tweehuysen L; Huiskes VJB; van den Bemt BJF; Vriezekolk JE; Teerenstra S; van den Hoogen FHJ; van den Ende CH; den Broeder AA
    Arthritis Rheumatol; 2018 Sep; 70(9):1408-1418. PubMed ID: 29609207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of extra-articular manifestations on tumor necrosis factor-α inhibitor treatment duration in patients with ankylosing spondylitis: nationwide data from the Korean College of Rheumatology BIOlogics (KOBIO) registry.
    Kim Y; Park S; Kim HS
    Clin Rheumatol; 2018 Dec; 37(12):3275-3284. PubMed ID: 30251059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computed tomography guided intra-articular injection of etanercept in the sacroiliac joint is an effective mode of treatment of ankylosing spondylitis.
    Cui Y; Xiao Z; Shuxia W; Zhenjun Z; Hengguo Z; Liangyi F; Weicheng G; Li L; Guangfeng Z; Yunzhen S; Guangfu D
    Scand J Rheumatol; 2010 May; 39(3):229-32. PubMed ID: 20109079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of Yisaipu tapering in the treatment of ankylosing spondylitis].
    Huang ZX; Guo XQ; Deng WM; Zheng SL; Guo X; Huang YK; Li TW
    Zhonghua Yi Xue Za Zhi; 2018 Apr; 98(15):1158-1161. PubMed ID: 29690728
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of needle-knife combined with etanercept treatment regarding disease activity and hip joint function in ankylosing spondylitis patients with hip joint involvement: A randomized controlled study.
    You Y; Cai M; Lin J; Liu L; Chen C; Wang Y; Cai Y
    Medicine (Baltimore); 2020 May; 99(19):e20019. PubMed ID: 32384461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
    McLeod C; Bagust A; Boland A; Dagenais P; Dickson R; Dundar Y; Hill RA; Jones A; Mujica Mota R; Walley T
    Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etanercept: in ankylosing spondylitis.
    McCormack PL; Wellington K
    BioDrugs; 2004; 18(3):199-205; discussion 206. PubMed ID: 15161337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.